Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases

Published on Dec 1, 2019in Translational lung cancer research
· DOI :10.21037/tlcr.2019.11.30
Zoltan Lohinai5
Estimated H-index: 5
Zsolt Megyesfalvi1
Estimated H-index: 1
+ 7 AuthorsFred R. Hirsch75
Estimated H-index: 75
Background: Recent preclinical data suggest that neuroendocrine (NE) subtype of small cell lung cancer (SCLC) has strong therapeutic relevance. NE high tumors are associated with immune desert and NE low tumors are considered to have an immune oasis phenotype. Our aim was to investigate the NE phenotypes of surgically resected SCLC tumors according to inter-tumor heterogeneity. Methods: Expression analysis for 2,560 genes was performed in 32 surgically resected SCLC patients’ primary tumors and corresponding lymph node (LN) metastases. To analyze tumor heterogeneity, we examined the differences in the gene expression of primary tumors versus LN metastases. We performed cluster analysis and heat map to divide patients into NE high and low subtypes by using the top NE-associated genes described in preclinical studies. Results: We found 6% (n=154) genes with significant differences and only 13.1% (n=336) of all genes in the panel had a strong correlation between the primary tumor and LN metastases. Cluster analysis clearly distinguished SCLC NE high versus low subtypes both in primary tumor (20 vs . 12, respectively) and LNs (23 vs . 9, respectively). As for inter-tumor heterogeneity, in case of five patients, a change in the NE pattern was observed. Specifically, we found significant downregulation of the NE-associated genes CAV1 (P=0.004), CAV2 (P=0.029) and ANXA3 (P=0.035) in their LN metastases compared to their primary tumor. Conclusions: Our data confirm the results of preclinical studies and clearly distinguish NE low and high differentiation clusters in SCLC. Moreover, they highlight the gene expression discordance between primary tumors and corresponding LN metastases suggesting that the NE pattern of metastatic LNs might not reflect that of the primary tumor. Altogether, by shedding light on the diversity of SCLC, the current study might help to improve patient selection and treatment in this devastating disease.
  • References (0)
  • Citations (1)
📖 Papers frequently viewed together
11 Authors (Sun Young Kwon, ..., Ji Young Park)
26 Citations
3 Citations
8 Authors (T Ahrends, ..., A. Zaczek)
78% of Scinapse members use related papers. After signing in, all features are FREE.
Cited By1
#1David Dora (Semmelweis University)H-Index: 2
#2Christopher J. Rivard (Anschutz Medical Campus)H-Index: 35
Last. Zsolt Megyesfalvi (Semmelweis University)H-Index: 1
view all 14 authors...
Small cell lung cancer (SCLC) has recently been sub-categorized into neuroendocrine (NE)-high and NE-low subtypes showing 9immune desert9 and 9immune oasis9 phenotypes, respectively. We aimed to characterize the immune cell localization and the microenvironment according to immune checkpoints and NE subtypes in human SCLC tissue samples at the protein level. In this cross-sectional study, we included 32 primary tumors and matched lymph node (LN) metastases of resected early-stage, histologically...